Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
about
Progress and perspectives on targeting nanoparticles for brain drug delivery.Development of targeted therapies in treatment of glioblastomaBrain tumor-targeted drug delivery strategiesPolymeric Nanostructures for Imaging and TherapyRadioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.Bionanotechnology and the future of glioma.Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Molecular targeting of glioblastoma: Drug discovery and therapiesPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityLong-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugatesApoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesShape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation.Challenges and opportunities in the advancement of nanomedicines.SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICETargeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle.Therapeutic nanomedicine for brain cancer.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Intra-arterial chemotherapy for malignant gliomas: a critical analysis.Which drug or drug delivery system can change clinical practice for brain tumor therapy?Targeted delivery of nano-therapeutics for major disorders of the central nervous system.Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.D-Peptides as Recognition Molecules and Therapeutic Agents.Perspectives on Dual Targeting Delivery Systems for Brain Tumors.Direct Solvent-Derived Polymer-Coated Nitrogen-Doped Carbon Nanodots with High Water Solubility for Targeted Fluorescence Imaging of Glioma.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Lipid nanoparticle delivery systems for siRNA-based therapeutics.Nanomaterial-Enabled Cancer Therapy.Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Nanoparticles squeezing across the blood-endothelial barrier via caveolae.Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma.Caveolae-mediated Delivery of Therapeutic Nanoparticles across Blood-endothelial Barrier.Differentiating brain radionecrosis from tumour recurrence: a role for contrast-enhanced ultrasound?
P2860
Q26740580-5D2A3A20-406F-421C-9B8F-7C1BE1DB1905Q26778787-A49081A1-84D0-49CB-9689-180B18DDD40AQ26829741-18700B11-C2C1-43C0-A64D-4104BB18955EQ30372383-10DC28EF-90DF-4EB4-A8D4-3EB4FC00E851Q30413615-DC8A7AA8-951A-4627-904F-0C8A8B2448C5Q30417964-7D226AE4-DBC8-49AA-BF39-4096A2597A98Q30672749-C6E649D1-691A-41B8-BBE0-AD49131EF8C5Q31065446-523777D7-97AA-4301-98B6-1ADADA0D5471Q33911283-3E23CCA6-54AA-4AED-AEFE-F45EEC6C25D5Q34083937-89E2E78F-D085-4053-842B-049F1EFF0D36Q34251745-1C03AC5E-49D2-4D1B-9A4B-B467C22675DAQ34728592-ACE1A2C6-17EC-4E36-976D-BD2BCAB2CE17Q35602796-6B314BEC-E8A6-44B5-A23E-7ED0EC42FDB4Q36289257-9B6577CF-7153-48B3-A071-3240DA03CAF0Q36390455-8174DACB-9CB9-45FA-BA50-BCF6CFD532ADQ36417295-7884E2DF-4269-4090-8159-5AAC60FE8233Q36710294-FF66F9E2-91AD-4495-B165-5D7920CB998DQ36936207-1BE7A6E4-E543-4C25-902E-0034C6F1B20BQ37292721-8AB66BF7-DE06-488C-858D-1050F49BB9BAQ37338427-4C994D9A-C544-48FC-A323-63F86905968CQ37346039-3F8F217E-49FF-4DED-8E10-9F4C28224271Q37517611-6EB8042C-6C36-4219-8EBA-18A030C7FB7FQ37561973-26223D00-04DE-46DE-91C1-24550718F92AQ37823446-2969875A-513D-4A4A-9CA9-BCB25D8853B2Q37946674-3659B89C-EADA-4FD6-B416-C407BC727F8BQ38090394-A2915792-24B5-4352-AF9B-1E6F340634C4Q38116765-7ECDEF96-6F2E-4C79-A70F-90D5449CBFC5Q38270095-FD4C8FB6-E93D-484B-BA7B-F412BD69399CQ38541950-168E8636-A739-466C-8749-27F51A2D5872Q38851989-58E10CAB-1BC7-458B-B93A-26296BE4B3A2Q38857119-FC098E67-118C-4F85-9226-183852B5870DQ38895211-D7B4E94A-06DC-4A79-95A2-6071C3E62E78Q38998571-A3C1BB44-AC42-45A5-873F-079AE3E0EA69Q39027758-26BD99B1-E410-42BF-8726-8D5968145F63Q39323096-3885149E-0F52-4831-A2FF-0E2F7D46E1E0Q39721426-DD31D4D5-F02A-4EFC-91F9-94922343E2FEQ40895124-8CAFBCEB-C9CA-40C5-AD63-E13FB94704A6Q42362427-B958D061-7594-44F6-8A1E-5703299BE68EQ42635523-25497FFC-719E-45E2-A9DD-D5D4296AA3EAQ45066603-5A39AE91-6497-4C13-9CCE-108BDCD3EE68
P2860
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@ast
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en-gb
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@nl
type
label
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@ast
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en-gb
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@nl
prefLabel
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@ast
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en-gb
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@nl
P2093
P2860
P3181
P356
P1476
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
@en
P2093
Alioscka A Sousa
Ariel S Kanevsky
Colin M Wilson
Gary L Griffiths
Hemant Sarin
Howard Q Vo
Maria A Aronova
P2860
P2888
P3181
P356
10.1186/1479-5876-7-51
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1023535340